SCHEMBL20623924

SCHEMBL20623924

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4ccc(-c5cc6c7ccccc7c7ccccc7c6c6ccccc56)cc4)c3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ HPGD P15428 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ ATM Q13315 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ GP6 Q9HCN6 1/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ACACA Q13085 2/20 0.38
▸ NTSR1 P30989 1/20 0.37
▸ MPI P34949 1/20 0.37
▸ MAPK1 P28482 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ RARA P10276 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20623982 1.00 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20624539 1.00 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623932 1.00 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623935 0.97 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20624087 0.95 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623925 0.95 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623980 0.95 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623975 0.95 GP6 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20623933 0.95 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20624287 0.95 GP6 (0.39) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190006598-A1 NOVEL COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190006598-A1 NOVEL COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, L1CAM, TMEM109 MEN1 587/4885KMT2A 2181/4885ALDH1A1 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback